Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 22.7B | 19.5B | 15.2B | 17.8B |
| Cost of revenue | 20.3B | 17.1B | 16.8B | 21.3B |
| Gross profit | 2.4B | 2.4B | -1.6B | -3.5B |
| Operating expense | ||||
| Research & development | 910M | 844M | 836M | 1.2B |
| Selling general and admin | 1.8B | 1.1B | 1.4B | 1.1B |
| Other operating expenses | — | — | — | — |
| Operating income | -268M | 461M | -3.8B | -5.7B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 710M | 708M | 755M | 728M |
| Other income expense | 417M | 323M | 485M | 250M |
| Pretax income | -561M | 76M | -4.1B | -6.2B |
| Tax provision | 51M | 107M | -232M | -50M |
| Net income | -612M | -31M | -3.9B | -6.2B |
| Basic EPS | -0.9 | -0.2 | -5.5 | -10.0 |
| Diluted EPS | -0.9 | -0.2 | -5.5 | -10.0 |
| Basic average shares | 664.1M | 768.8M | 707.9M | 618.9M |
| Diluted average shares | 664.1M | 768.8M | 718.1M | 618.9M |
| EBITDA | 517M | 1.3B | -2.9B | -5.0B |
| Net income from continuing op. | -612M | -31M | -3.9B | -6.2B |
| Minority interests | 1M | -6M | -4M | 4M |
| Preferred stock dividends | — | — | — | — |